One of the most efficient screening assay designs is an arranged series of small Overlapping Peptides, each with a defined length and offset to maximise usefulness.

Finding T-cell Epitopes

The properties of T-cell epitopes lend themselves to studies utilising Overlapping PepSet™ Peptide Libraries. These short, linear sequences from the primary protein can be mapped easily with unmodified, unpurified peptide libraries.

Research Strategies

  • T-cell epitope mapping
  • Antibody epitope mapping
  • Antigen epitope mapping
  • Screening proteins to identify substrates
  • Searching proteins for binding sites
  • T-cell stimulation assays

With minor modifications, the already versatile Overlapping Peptide Libraries can be diversified to include applications  in immunology, pharmacology, biochemistry, drug discovery and development, immunodiagnostic testing and vaccine development, to name a few. There are virtually limitless options for modifications, including biotinylation and bioconjugation. 

Fast and Direct Answers

The Overlapping Peptide design allows for thorough searching of the primary protein sequence without the difficulty of having to synthesise and utilise a peptide of comparable length. These PepSets™ can be used immediately for fast results.

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

✉ australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

 useast@mimotopes.com

uswest@mimotopes.com



asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com


UK / Europe / Africa / Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Contact us today for a quote! 

Australia

☎ +61 3 9565 1111

australia@mimotopes.com

North and South America 

☎ +1 651 603 0909

  ✉ useast@mimotopes.com 
  ✉ uswest@mimotopes.com

asia

☎ +61 3 9565 1111

✉ asia@mimotopes.com

UK/ Europe/ Africa/ Middle East

☎ +44 (0)151 556 0547

✉ europe@mimotopes.com

Go to article: Home | Unpacking innovation in biologics Go to article: In this issueGo to article: ContentsGo to article: MyonexGo to article: Controlant Company InsightGo to article: ControlantGo to article: SHL MedicalGo to article: LabcorpGo to article: ReutersGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: TQS Integration Company InsightGo to article: TQS IntergrationGo to article: Biesterfeld Go to article: CommentGo to article: Biotech and China: a global opportunityGo to article: Intranasal ketamine could effectively treat phantom painGo to article: EU biosimilar wave slows as biosimilar approvals decrease in the EUGo to article: Biosynth Carbosynth Company InsightGo to article: Biosynth CarbosynthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: SkyepharmaGo to article: In DepthGo to article: Unpacking the complex challenge of biologicsGo to article: Living medicines: using bacteria to fight cancerGo to article: The marred history of HIV vaccine trialsGo to article: Has Covid-19 exposed the weakness of the US pharma supply chain?Go to article: How the pandemic pushed pharmacovigilance to innovateGo to article: ExeVir: the llama-derived antibody that could fight Covid-19Go to article: BEA TechnologiesGo to article: WatlowGo to article: DuojectGo to article: ButterworthGo to article: In DataGo to article: Data: Big Data hiring efforts in pharmaGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue